Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDGenprex Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$6,160.00 | -$6,160.00 | -$6,160.00 |
| Q2 2026 | 1 | -$5,720.00 | -$5,720.00 | -$5,720.00 |
| Q1 2027 | 1 | -$3,080.00 | -$3,080.00 | -$3,080.00 |
| Q2 2027 | 1 | -$4,400.00 | -$4,400.00 | -$4,400.00 |
| Q3 2027 | 1 | -$5,280.00 | -$5,280.00 | -$5,280.00 |
| Q4 2027 | 1 | -$4,840.00 | -$4,840.00 | -$4,840.00 |
| Q1 2028 | 1 | -$5,720.00 | -$5,720.00 | -$5,720.00 |
| Q2 2028 | 1 | -$5,720.00 | -$5,720.00 | -$5,720.00 |
| Q3 2028 | 1 | -$7,040.00 | -$7,040.00 | -$7,040.00 |
| Q4 2028 | 1 | -$5,720.00 | -$5,720.00 | -$5,720.00 |
| Q1 2029 | 1 | -$4,400.00 | -$4,400.00 | -$4,400.00 |
| Q2 2029 | 1 | -$6,044.50 | -$6,044.50 | -$6,044.50 |
| Q3 2029 | 1 | -$4,059.00 | -$4,059.00 | -$4,059.00 |
| Q4 2029 | 1 | -$3,300.00 | -$3,300.00 | -$3,300.00 |
| Q1 2030 | 1 | -$1,353.00 | -$1,353.00 | -$1,353.00 |
| Q2 2030 | 1 | -$429.00 | -$429.00 | -$429.00 |
| Q3 2030 | 1 | -$451.00 | -$451.00 | -$451.00 |
| Q4 2030 | 1 | -$462.00 | -$462.00 | -$462.00 |
| Q1 2031 | 1 | -$275.00 | -$275.00 | -$275.00 |
| Q2 2031 | 1 | -$286.00 | -$286.00 | -$286.00 |
Genprex Inc Earnings Date And Information
Genprex Inc last posted its earnings results on Monday, March 30th, 2026. The company reported $-25.3 earnings per share for the quarter, topping analysts' consensus estimates of $-286 by $260.7. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Genprex Inc has generated $-383 earnings per share over the last year ($-382.8 diluted earnings per share) and currently has a price-to-earnings ratio of -0.02. Genprex Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Genprex Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/14/2026 | Q2 2026 | N/A | -$9.40 | N/A | N/A | $0 |
| 05/13/2026 | Q1 2026 | N/A | -$14.08 | N/A | N/A | $0 |
| 03/30/2026 | Q4 2025 | -$286.00 | -$25.30 | 260.7 | N/A | $0 |
| 11/14/2025 | Q3 2025 | -$275.00 | -$110.00 | 165 | N/A | $0 |
| 06/30/2025 | Q2 2025 | N/A | -$187.00 | N/A | N/A | $0 |
| 05/12/2025 | Q1 2025 | -$55.88 | -$286.00 | -230.12 | N/A | $0 |
| 03/31/2025 | Q4 2024 | -$18.04 | -$462.00 | -443.96 | N/A | $0 |
| 11/13/2024 | Q3 2024 | -$1,241.76 | -$1,353.00 | -111.24 | N/A | $0 |
| 08/09/2024 | Q2 2024 | N/A | -$3,300.00 | N/A | N/A | $0 |
| 05/15/2024 | Q1 2024 | -$55.88 | -$4,059.00 | -4003.12 | N/A | $0 |
| 04/01/2024 | Q4 2023 | -$86.46 | -$4,389.00 | -4302.54 | N/A | $0 |
| 11/14/2023 | Q3 2023 | -$2.42 | -$5,896.00 | -5893.58 | N/A | $0 |
| 08/21/2023 | Q2 2023 | -$114.40 | -$6,754.00 | -6639.6 | N/A | $0 |
| 05/22/2023 | Q1 2023 | -$2.64 | -$8,184.00 | -8181.36 | N/A | $0 |
| 03/31/2023 | Q4 2022 | -$114.40 | -$5,863.00 | -5748.6 | N/A | $0 |
| 11/14/2022 | Q3 2022 | -$2.64 | -$5,555.00 | -5552.36 | N/A | $0 |
| 08/12/2022 | Q2 2022 | -$4,395.60 | -$5,302.00 | -906.4 | N/A | $0 |
| 05/13/2022 | Q1 2022 | -$3,956.04 | -$5,258.00 | -1301.96 | N/A | $0 |
| 03/30/2022 | Q4 2021 | -$88.00 | -$5,225.00 | -5137 | N/A | $0 |
| 11/15/2021 | Q3 2021 | N/A | -$3,179.00 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Genprex Inc Earnings: FAQ's
In the previous quarter, Genprex Inc (:GNPX) reported $-25.3 earnings per share (EPS) to beat the analysts' consensus estimate of $-286 by $260.7.
The conference call for Genprex Inc's latest earnings report can be listened to online.
The conference call transcript for Genprex Inc's latest earnings report can be read online.
Genprex Inc (:GNPX) has a recorded net income of $-16,228,953.Genprex Inc has generated $-382.8 earnings per share over the last four quarters.
Genprex Inc (:GNPX) has a price-to-earnings ratio of -0.02 and price/earnings-to-growth ratio is -0.